Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 2
2016 2
2017 2
2018 2
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.
van Waateringe RP, Fokkens BT, Slagter SN, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, Paterson AD, Smit AJ, Lutgers HL, Wolffenbuttel BHR. van Waateringe RP, et al. Among authors: fokkens bt. Diabetologia. 2019 Feb;62(2):269-280. doi: 10.1007/s00125-018-4769-x. Epub 2018 Nov 21. Diabetologia. 2019. PMID: 30460578 Free PMC article.
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Wouters EF, et al. Among authors: fokkens b. Thorax. 2005 Jun;60(6):480-7. doi: 10.1136/thx.2004.034280. Thorax. 2005. PMID: 15923248 Free PMC article. Clinical Trial.
[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group. Wouters EF, et al. Among authors: fokkens b. Rev Port Pneumol. 2005 Nov-Dec;11(6):587-9. Rev Port Pneumol. 2005. PMID: 16514718 Portuguese. No abstract available.